<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD2954394">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo>
                        <title>Peptidotriazolamers Inhibit Abeta(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model</title>
                    </titleInfo>
                    <name type="personal">
                        <namePart type="given">Nicolo Michele</namePart>
                        <namePart type="family">Tonali</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Loreen</namePart>
                        <namePart type="family">Hericks</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">David C.</namePart>
                        <namePart type="family">Schröder</namePart>
                        <nameIdentifier type="orcid" typeURI="http://orcid.org">0000-0002-7249-4156</nameIdentifier>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Oliver</namePart>
                        <namePart type="family">Kracker</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Radoslaw</namePart>
                        <namePart type="family">Krzemieniecki</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Julia</namePart>
                        <namePart type="family">Kaffy</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Vadim</namePart>
                        <namePart type="family">Le Joncour</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Pirjo</namePart>
                        <namePart type="family">Laakkonen</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Antoine</namePart>
                        <namePart type="family">Marion</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Sandrine</namePart>
                        <namePart type="family">Ongeri</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Veronica Isabel</namePart>
                        <namePart type="family">Dodero</namePart>
                        <nameIdentifier type="orcid" typeURI="http://orcid.org">0000-0001-7937-1880</nameIdentifier>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Norbert</namePart>
                        <namePart type="family">Sewald</namePart>
                        <nameIdentifier type="orcid" typeURI="http://orcid.org">0000-0002-0309-2655</nameIdentifier>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf">2021</dateIssued>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">In peptidotriazolamers every second peptide bond is replaced by a 1H-1,2,3-triazole. Such foldamers are expected to bridge the gap in molecular weight between small-molecule drugs and protein-based drugs. Amyloid beta (Abeta) aggregates play an important role in Alzheimer&apos;s disease. We studied the impact of amide bond replacements by 1,4-disubstituted 1H-1,2,3-triazoles on the inhibitory activity of the aggregation &quot;hot spots&quot; K16 LVFF20 and G39 VVIA42 in Abeta(1-42). We found that peptidotriazolamers act as modulators of the Abeta(1-42) oligomerization. Some peptidotriazolamers are able to interfere with the formation of toxic early Abeta oligomers, depending on the position of the triazoles, which is also supported by computational studies. Preliminary in vitro results demonstrate that a highly active peptidotriazolamer is also able to cross the blood-brain-barrier. © 2021 The Authors. ChemPlusChem published by Wiley-VCH GmbH.</abstract>
                    <subject>
                    </subject>
                    <classification authority="ddc">540</classification>
                    <relatedItem type="host">
                        <titleInfo>
                            <title>ChemPlusChem</title>
                        </titleInfo>
                        <part>
                            <detail type="volume">
                                <number>86</number>
                            </detail>
                            <detail type="issue">
                                <number>6</number>
                            </detail>
                            <extent unit="page">
                                <start>840</start>
                                <end>851</end>
                            </extent>
                        </part>
                    </relatedItem>
                    <identifier type="eIssn">2192-6506</identifier>
                    <identifier type="MEDLINE">33905181</identifier>
                    <identifier type="ISI">000647850200001</identifier>
                    <identifier type="urn">urn:nbn:de:0070-pub-29543940</identifier>
                    <identifier type="doi">10.1002/cplu.202000814</identifier>
                    <accessCondition type="use and reproduction" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0</accessCondition>
                    <recordInfo>
                        <recordIdentifier>bielefeld_pub_2954394</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE0_bielefeld_pub_2954394">
                <mets:FLocat xlink:href="https://pub.uni-bielefeld.de/download/2954394/2957771/cplu.202000814.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="bielefeld_pub_2954394" DMDID="DMD2954394">
            <mets:fptr FILEID="FILE0_bielefeld_pub_2954394"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
